| Literature DB >> 32939111 |
Santosh Dey1, Vishesh Jain2, Sachit Anand2, Sandeep Agarwala2, Anjan Dhua1, M Srinivas2, Veereshwar Bhatnagar2.
Abstract
PURPOSE: To identify complications, their incidence and risk factors for their occurrence in patients of esophageal atresia (EA) in the 1st year after discharge following surgery.Entities:
Keywords: Congenital malformation; esophageal anastomosis; esophageal atresia; tracheoesophageal fistula
Year: 2020 PMID: 32939111 PMCID: PMC7478287 DOI: 10.4103/jiaps.JIAPS_88_19
Source DB: PubMed Journal: J Indian Assoc Pediatr Surg ISSN: 0971-9261
Figure 1Distribution of cohort (n= 70); EA + TEF: Esophageal atresia with tracheoesophageal fistula, EA: Esophageal atresia, TEF: Tracheoesophageal fistula
Associated congenital anomalies in the cohort
| Congenital anomalies | |
|---|---|
| Cardiovascular | 51 (72) |
| Vertebral | 5 (7) |
| VACTERL | 2 (2.8) |
| Anorectal malformation | 4 (5.7) |
| Gastrointestinal | 3 (4.2) 1 each with duodenal atresia, pyloric stenosis, and annular pancreas |
Risk of developing complications in the first 12 months following discharge
| Group | Number of patients | Risk of any complication | ||
|---|---|---|---|---|
| Frequency (%) | Relative risk | |||
| Type of atresia | ||||
| EA + TEF | 65 | 45 (69.2) | 0.6 | 1.15 |
| EA | 5 | 3 (60) | ||
| Status of esophagus at discharge | ||||
| Maintained continuity | 48 | 35 (72.9) | 0.2 | 1.23 |
| Diverted | 22 | 13 (59.1) | ||
| History of anastomotic leak | ||||
| Yes | 14 | 10 (71.4) | 0.8 | 1.03 |
| No | 42 | 29 (69) | ||
| Cardiac anomaly | ||||
| Present | 51 | 37 (72.5) | 0.1 | 1.3 |
| Absent | 19 | 10 (55.5) | ||
EA: Esophageal atresia, TEF: Tracheoesophageal fistula
Overall survival within different subgroups lower respiratory tract infection
| Group, | Number of deaths | 1-year OS, % | Relative risk of death | |
|---|---|---|---|---|
| Type of atresia | ||||
| EA + TEF, 65 | 19 | 70.7 | 0.5 | 1.86 |
| EA, 5 | 2 | 60 | ||
| Status of esophagus | ||||
| Diverted, 22 | 12 | 45.4 | 0.001 | 3.71 |
| Maintained continuity, 48 | 9 | 81.25 | ||
| Maturity at presentation | ||||
| Preterm, 25 | 12 | 52 | 0.015 | 3.09 |
| Term, 45 | 9 | 80 | ||
| Development of LRTI | ||||
| Yes, 31 | 13 | 58 | 0.06 | 2.26 |
| No, 39 | 8 | 79.4 |
LRTI: Lower respiratory tract infection, OS: Overall survival, EA: Esophageal atresia, TEF: Tracheoesophageal fistula
Figure 2Kaplan–Meier survival estimate (1-year overall survival: Diverted group = 45.4%; maintained continuity group = 81.2%,P= 0.001, relative risk = 3.71 [95% confidence interval 1.56–8.84])